|
0
|
|
Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients.
(journals.asm.org)
|
Wang X
…
Zhao D
mSystems
2026-04-21
|
#microbiota
#inflammation
#metabolomics
#dysbiosis
#immunotherapy
|
|
0
|
|
CAR-M2 immunotherapy resolves renal fibrosis via revascularization and apoptosis of profibrotic Cxcr2(+) endothelial cells.
(linkinghub.elsevier.com)
|
Zhao W
…
Zeng W
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#fibrosis
#transcriptomics
#apoptosis
#macrophage
|
|
0
|
|
The microbial metabolome: remodeling the therapeutic landscape in hematologic malignancies.
(nature.com)
|
Zhang L
…
Gafarov R
npj Biofilms and Microbiomes
2026-04-21
|
#microbiome
#metabolism
#cancer
#immunotherapy
#chemotherapy
|
|
0
|
|
Immunogenic tumor cell death and T-cell-derived IFN-gamma elicit tumoricidal macrophages to potentiate OX40 immunotherapy.
(linkinghub.elsevier.com)
|
Liu Y
…
Zhang H
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#macrophage
#tumor microenvironment
#cancer
#immunity
|
|
0
|
|
Combination immunotherapy for colorectal cancer: Clinical applications, rationale, challenges, and future perspectives.
(linkinghub.elsevier.com)
|
Fei J
…
Zeng S
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#cancer
#tme
#biomarker
|
|
0
|
|
A senescent tumor cell-derived nanovesicle directly primes splenic T cells to potentiate cancer radiotherapy.
(linkinghub.elsevier.com)
|
Pan J
…
Lai Y
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#senescence
#nanovesicles
#cancer
#immunity
|
|
0
|
|
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Adan-Villaescusa E
…
Fernandez-Barrena MG
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#cancer
#epigenetics
#immunity
#hepatocellular carcinoma
|
|
0
|
|
Single-cell analysis highlights the significance of malignant cell IFN/MHC-II for immunotherapy response in head and neck squamous cell carcinoma.
(linkinghub.elsevier.com)
|
Mints M
…
Puram SV
Cell Reports Medicine
2026-04-21
|
#transcriptomics
#immunotherapy
#cancer
#immunity
#biomarker
|
|
0
|
|
Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma.
(linkinghub.elsevier.com)
|
Lin Y
…
Fan J
Cell Reports Medicine
2026-04-21
|
#transcriptomics
#heterogeneity
#cancer
#immunotherapy
#biomarker
|
|
0
|
|
HE4 drives PD-L1 expression in myeloid cells via IFN-gammaR-JAK-STAT3 signaling to promote tumor immune evasion.
(linkinghub.elsevier.com)
|
Zeng B
…
Wang C
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#checkpoint
#signaling
#biomarker
#cancer
|
|
0
|
|
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanoma.
(linkinghub.elsevier.com)
|
Wei S
…
Zhang G
Cell Reports Medicine
2026-04-21
|
#amr
#immunotherapy
#melanoma
#single-cell
|
|
0
|
|
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer.
(linkinghub.elsevier.com)
|
Ning W
…
Luo W
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#cancer
#antibody
#therapeutics
#cytotoxicity
|
|
0
|
|
mRNA lipid-nanoparticle-mediated mitochondrial apoptosis augments adoptive T cell immunotherapy.
(linkinghub.elsevier.com)
|
Fu J
…
Jin Y
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#apoptosis
#transcriptomics
#cancer
#rna
|
|
0
|
|
Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment.
(linkinghub.elsevier.com)
|
Yeo YY
…
Jiang S
Cell Reports Medicine
2026-04-21
|
#lymphoma
#immunity
#immunotherapy
#proteomics
#spatial omics
|
|
0
|
|
Self-adjuvanting alpha-helical polypeptide simultaneously delivers neoantigen mRNAs and activates dendritic cells to eradicate tumors.
(pnas.org)
|
Han J
…
Wang H
PNAS
2026-04-21
|
#dendritic cell
#vaccination
#immunotherapy
#neoantigen
#cancer
|
|
0
|
|
Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8(+) T cell immunity via rewiring MHC-I antigen presentation.
(linkinghub.elsevier.com)
|
Feng H
…
Xing F
Cell Reports Medicine
2026-04-21
|
#immunotherapy
#oncolytic
#cancer
#immunity
#engineering
|
|
0
|
|
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity.
(linkinghub.elsevier.com)
|
Ma Y
…
Weng S
Cell Reports Medicine
2026-04-21
|
#immunity
#inflammation
#immunotherapy
#neurotoxicity
#cytokine
|